37. 膿疱性乾癬(汎発型) Generalised pustular psoriasis Clinical trials / Disease details


臨床試験数 : 79 薬物数 : 57 - (DrugBank : 21) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 102

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-003922-70-DE
(EUCTR)
28/11/200708/08/2007Uncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumab in patients with moderate to severe palmoplantar pustular psoriasis (PPP) - PPP StudyUncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumab in patients with moderate to severe palmoplantar pustular psoriasis (PPP) - PPP Study moderate to severe palmoplantar pustular psoriasis
MedDRA version: 9.1;Level: LLT;Classification code 10037159;Term: Psoriasis pustular
Trade Name: Raptiva
INN or Proposed INN: Efalizumab
Technische Universität DresdenNULLNot RecruitingFemale: yes
Male: yes
42Phase 2Germany